Outlook and future of inner ear therapy

Area of Science:

• Otolaryngology
• Pharmacology
• Biotechnology

Background:

• Inner ear drug delivery is crucial for treating diverse otologic conditions.
• Emerging technologies and pharmacokinetic principles are revolutionizing inner ear drug delivery.
• Current approaches are limited by challenges in understanding disease etiology and diagnostics.

Purpose of the Study:

• To review novel drug delivery methods for inner ear disorders.
• To explore future therapeutic strategies and delivery systems.
• To discuss challenges and considerations for clinical translation.

Main Methods:

• Review of current literature on inner ear drug delivery systems.
• Analysis of emerging technologies such as gene therapy and stem cells.
• Discussion of pharmacokinetic principles and cell-specific targeting strategies.

Main Results:

• Novel delivery systems and drug-device combinations are advancing inner ear therapy.
• Strategies include gene expression manipulation, local activation, stem cells, viral vectors, and gene editing.
• Significant challenges remain, including risks of trauma, limited etiological understanding, and diagnostic tool scarcity.

Conclusions:

• Inner ear drug delivery holds immense potential for otologic treatments.
• Overcoming clinical translation challenges requires further research in safety, diagnostics, and disease understanding.
• Future directions focus on integrated approaches combining advanced delivery systems with novel therapeutic modalities.